Portfolio Holdings Detail for ISIN IE00BFNM3H51
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / Fund iShares MSCI USA ESG Screened UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker SDUS(USD) LSE
ETF Ticker SLUS(EUR) F
ETF Ticker SDUS.LS(USD) CXE
ETF Ticker SLUS.DE(EUR) CXE
ETF Ticker SDUS.L(GBP) LSE

Holdings detail for EW

Stock Name	Edwards Lifesciences Corp
Ticker	EW(USD) NYSE
TYPE	Common Stock
Country	USA
ISIN	US28176E1082
LEI	YA13X31F3V31L8TMPR58

Show aggregate EW holdings

News associated with EW

Edwards Lifesciences (NYSE:EW) Cut to Buy at Wall Street Zen: Edwards Lifesciences (NYSE:EW – Get Free Report) was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a note issued to investors on Saturday. A number of other research analysts have also issued reports on the company. Wells Fargo & Company boosted their price objective on Edwards Lifesciences […] - 2025-09-15 05:40:50
Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings: Key PointsKen Griffin founded the hedge fund firm Citadel. - 2025-09-09 12:44:48
Top Stock Reports for Apple, Novartis & Charles Schwab: Apple grows Services to 1B+ paid subscribers, while Novartis lifts guidance and Schwab rides higher rates to asset gains. - 2025-09-04 17:29:00
Atria Wealth Solutions Inc. Sells 29,763 Shares of Edwards Lifesciences Corporation (NYSE:EW): Atria Wealth Solutions Inc. cut its position in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 81.7% during the 1st quarter, HoldingsChannel reports. The firm owned 6,662 shares of the medical research company’s stock after selling 29,763 shares during the period. Atria Wealth Solutions Inc.’s holdings in Edwards Lifesciences were worth $483,000 as […] - 2025-08-14 05:04:55
Edwards Lifesciences (NYSE:EW) Raised to Buy at BTIG Research: Edwards Lifesciences (NYSE:EW – Get Free Report) was upgraded by investment analysts at BTIG Research from a “neutral” rating to a “buy” rating in a note issued to investors on Tuesday, Marketbeat reports. The firm currently has a $100.00 target price on the medical research company’s stock. BTIG Research’s price target points to a potential […] - 2025-07-31 03:02:52
Edwards Lifesciences (NYSE:EW) Upgraded at Wall Street Zen: Wall Street Zen upgraded shares of Edwards Lifesciences (NYSE:EW – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday. Several other research analysts have also weighed in on EW. Wells Fargo & Company lifted their price objective on Edwards Lifesciences from $80.00 to $84.00 and […] - 2025-07-29 02:58:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 13:25:48
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 12:26:28
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 09:49:10
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 08:57:30
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 07:43:41
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 04:16:07
Edwards Lifesciences (NYSE:EW) Price Target Raised to $82.00: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective upped by Truist Financial from $81.00 to $82.00 in a research note published on Friday,Benzinga reports. They currently have a hold rating on the medical research company’s stock. A number of other research firms have also weighed in on EW. Wall Street Zen lowered shares […] - 2025-07-28 04:08:50
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its price target increased by JPMorgan Chase & Co. from $80.00 to $85.00 in a report published on Friday morning,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the medical research company’s stock. Several other brokerages also recently issued reports on EW. Wells Fargo & […] - 2025-07-28 04:08:48
Edwards Lifesciences (NYSE:EW) Price Target Raised to $95.00: Edwards Lifesciences (NYSE:EW – Free Report) had its price target raised by Barclays from $90.00 to $95.00 in a report published on Friday,Benzinga reports. Barclays currently has an overweight rating on the medical research company’s stock. A number of other equities analysts have also weighed in on the stock. Deutsche Bank Aktiengesellschaft lifted their price […] - 2025-07-28 02:46:53
Stifel Nicolaus Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price: Edwards Lifesciences (NYSE:EW – Free Report) had its target price upped by Stifel Nicolaus from $90.00 to $95.00 in a research report sent to investors on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. EW has been the topic of several other research reports. Evercore ISI increased […] - 2025-07-28 02:46:53
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Robert W. Baird Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its target price boosted by Robert W. Baird from $78.00 to $79.00 in a research report report published on Friday morning,Benzinga reports. Robert W. Baird currently has a neutral rating on the medical research company’s stock. Other research analysts have also issued reports about the stock. Evercore ISI […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Price Target Raised to $80.00: Edwards Lifesciences (NYSE:EW – Free Report) had its target price lifted by Evercore ISI from $77.00 to $80.00 in a research report report published on Friday,Benzinga reports. The firm currently has an in-line rating on the medical research company’s stock. A number of other brokerages have also issued reports on EW. Argus upgraded shares of […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective lifted by Wells Fargo & Company from $80.00 to $84.00 in a report released on Friday morning,Benzinga reports. They currently have an overweight rating on the medical research company’s stock. A number of other research analysts also recently commented on EW. Dbs Bank raised shares […] - 2025-07-28 02:46:49
Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective increased by Deutsche Bank Aktiengesellschaft from $85.00 to $94.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. Several other equities analysts have also issued reports on EW. Dbs Bank upgraded […] - 2025-07-28 02:46:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 02:37:03
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 19:42:53
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:56:19
Positive Earnings Results Lift Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 14:23:43
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:18:44
Positive Earnings Results Lift Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 12:39:11
J.W. Cole Advisors Inc. Has $814,000 Stock Holdings in Edwards Lifesciences Corporation (NYSE:EW): J.W. Cole Advisors Inc. raised its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 220.2% in the 1st quarter, HoldingsChannel reports. The fund owned 11,224 shares of the medical research company’s stock after acquiring an additional 7,719 shares during the period. J.W. Cole Advisors Inc.’s holdings in Edwards Lifesciences were worth $814,000 at […] - 2025-07-25 05:12:50
Sigma Planning Corp Has $294,000 Position in Edwards Lifesciences Corporation (NYSE:EW): Sigma Planning Corp boosted its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 4.9% in the 1st quarter, HoldingsChannel.com reports. The firm owned 4,055 shares of the medical research company’s stock after acquiring an additional 191 shares during the quarter. Sigma Planning Corp’s holdings in Edwards Lifesciences were worth $294,000 as of its […] - 2025-07-21 05:06:55
Edwards Lifesciences Corporation (NYSE:EW) Position Lowered by Ballentine Partners LLC: Ballentine Partners LLC decreased its stake in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 6.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,109 shares of the medical research company’s stock after selling 375 shares during the period. Ballentine Partners LLC’s holdings […] - 2025-07-16 06:51:32
Alps Advisors Inc. Purchases Shares of 5,090 Edwards Lifesciences Corporation (NYSE:EW): Alps Advisors Inc. bought a new position in Edwards Lifesciences Corporation (NYSE:EW – Free Report) during the 1st quarter, HoldingsChannel reports. The fund bought 5,090 shares of the medical research company’s stock, valued at approximately $369,000. A number of other hedge funds have also recently added to or reduced their stakes in the stock. Norges […] - 2025-07-16 06:01:07

iShares MSCI USA ESG Screened UCITS ETF USD (Dist) EW holdings

Date	Number of EW Shares Held	Base Market Value of EW Shares	Local Market Value of EW Shares	Change in EW Shares Held	Change in EW Base Value	Current Price per EW Share Held	Previous Price per EW Share Held
2025-09-29 (Monday)	178,131	USD 13,749,932	USD 13,749,932
2025-09-26 (Friday)	177,390	USD 13,525,988	USD 13,525,988
2025-09-25 (Thursday)	175,722	USD 13,226,595	USD 13,226,595	117	USD 115,926	USD 75.27	USD 74.66
2025-09-24 (Wednesday)	175,605	USD 13,110,669	USD 13,110,669
2025-09-18 (Thursday)	173,389	USD 12,926,150	USD 12,926,150	468	USD -77,509	USD 74.55	USD 75.2
2025-09-17 (Wednesday)	172,921	USD 13,003,659	USD 13,003,659	585	USD 62,949	USD 75.2	USD 75.09
2025-09-16 (Tuesday)	172,336	USD 12,940,710	USD 12,940,710	936	USD -94,260	USD 75.09	USD 76.05
2025-09-15 (Monday)	171,400	USD 13,034,970	USD 13,034,970
2025-09-12 (Friday)	171,096	USD 13,271,917	USD 13,271,917

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of EW by Blackrock for IE00BFNM3H51

Show aggregate share trades of EW

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-25 BUY 117 75.270* 72.68
2025-09-18 BUY 468 74.550* 72.67
2025-09-17 BUY 585 75.200* 72.66
2025-09-16 BUY 936 75.090* 72.65
2025-08-15 BUY 76 78.260* 72.58
2025-08-13 BUY 39 77.680* 72.55
2025-08-08 BUY 339 78.350* 72.52
2025-08-06 BUY 716 78.610* 72.45
2025-07-31 BUY 195 79.310* 72.37
2025-07-29 BUY 780 80.470* 72.27
2025-07-11 BUY 312 78.050* 72.23
2025-07-10 BUY 351 78.800* 72.19
2025-07-09 BUY 351 77.190* 72.16
2025-07-07 SELL -234 76.690* 72.11 Profit of 16,874 on sale
2025-07-02 SELL -958 77.020* 72.02 Profit of 68,995 on sale
2025-06-27 BUY 122 78.210* 71.94
2025-06-26 BUY 117 77.150* 71.91
2025-06-24 SELL -546 75.850* 71.85 Profit of 39,230 on sale
2025-06-18 BUY 312 73.980* 71.78
2025-06-17 BUY 117 73.270* 71.77
2025-06-16 SELL -159 74.820* 71.75 Profit of 11,409 on sale
2025-06-12 SELL -195 75.890* 71.73 Profit of 13,987 on sale
2025-06-11 BUY 413 75.470* 71.70
2025-06-06 BUY 117 77.520* 71.60
2025-06-05 BUY 546 77.770* 71.55
2025-06-04 BUY 76 77.850* 71.51
2025-06-03 SELL -38 77.720* 71.47 Profit of 2,716 on sale
2025-05-30 SELL -4,636 78.220* 71.37 Profit of 330,866 on sale
2025-05-29 BUY 106 77.730* 71.32
2025-05-27 BUY 652 76.220* 71.25
2025-05-23 BUY 540 74.990* 71.19
2025-05-22 BUY 266 74.790* 71.16
2025-05-19 BUY 228 78.040* 71.02
2025-05-16 BUY 114 78.000* 70.97
2025-05-15 SELL -76 76.880* 70.92 Profit of 5,390 on sale
2025-05-14 BUY 38 76.750* 70.87
2025-05-13 BUY 76 75.500* 70.84
2025-05-12 BUY 246 74.800* 70.80
2025-05-09 SELL -190 73.680* 70.78 Profit of 13,448 on sale
2025-05-08 BUY 76 74.630* 70.75
2025-05-07 BUY 114 75.040* 70.71
2025-05-02 BUY 4,218 75.650* 70.60
2025-04-30 BUY 1,330 75.490* 70.52
2025-04-29 BUY 333 76.280* 70.47
2025-04-28 BUY 266 75.540* 70.42
2025-04-25 BUY 684 76.040* 70.37
2025-04-24 SELL -798 75.130* 70.33 Profit of 56,123 on sale
2025-04-23 BUY 722 70.460* 70.33
2025-04-22 BUY 304 70.600* 70.33
2025-04-17 BUY 418 71.530* 70.31
2025-04-15 BUY 380 70.760* 70.30
2025-04-11 BUY 608 69.400* 70.31
2025-04-09 BUY 228 69.900* 70.34
2025-04-08 BUY 1,368 67.070* 70.37
2025-04-07 BUY 450 69.000* 70.39
2025-04-04 SELL -608 69.360* 70.40 Profit of 42,801 on sale
2025-04-02 BUY 5,168 72.050* 70.38
2025-04-01 BUY 38 71.870* 70.36
2025-03-31 BUY 266 72.480* 70.34
2025-03-28 BUY 152 70.910* 70.33
2025-03-27 BUY 72 71.190* 70.33
2025-03-26 BUY 38 71.090* 70.32
2025-03-25 BUY 418 71.240* 70.31
2025-03-24 BUY 468 71.350* 70.30
2025-03-21 SELL -152 70.460* 70.29 Profit of 10,685 on sale
2025-03-20 BUY 608 70.950* 70.29
2025-03-19 BUY 108 70.900* 70.28
2025-03-18 BUY 1,328 70.340* 70.28
2025-03-17 BUY 266 70.630* 70.27
2025-03-14 BUY 1,976 69.290* 70.29
2025-03-13 BUY 380 67.950* 70.31
2025-03-12 SELL -1,900 68.510* 70.34 Profit of 133,639 on sale
2025-03-11 SELL -1,406 68.390* 70.36 Profit of 98,927 on sale
2025-03-10 BUY 418 68.530* 70.38
2025-03-07 BUY 76 70.330* 70.38
2025-03-05 BUY 570 72.850* 70.35
2025-03-04 BUY 646 71.380* 70.34
2025-03-03 BUY 1,216 71.390* 70.32
2025-02-28 BUY 988 71.620* 70.31
2025-02-27 SELL -190 71.400* 70.29 Profit of 13,356 on sale
2025-02-25 BUY 1,406 71.450* 70.25
2025-02-21 BUY 152 73.300* 70.17
2025-02-18 SELL -342 75.670* 69.96 Profit of 23,926 on sale
2025-02-14 SELL -2,318 76.190* 69.77 Profit of 161,717 on sale
2025-02-13 BUY 38 76.000* 69.67
2025-02-12 BUY 374 75.820* 69.57
2025-02-07 SELL -53 70.350* 69.51 Profit of 3,684 on sale
2025-02-06 BUY 722 70.990* 69.48
2025-02-05 BUY 190 72.100* 69.44
2025-02-04 BUY 228 71.330* 69.41
2025-02-03 BUY 228 71.380* 69.37
2025-01-31 BUY 418 72.450* 69.32
2025-01-29 SELL -38 71.130* 69.21 Profit of 2,630 on sale
2025-01-28 SELL -342 72.560* 69.14 Profit of 23,647 on sale
2025-01-27 SELL -608 69.200* 69.14 Profit of 42,038 on sale
2025-01-24 BUY 456 68.990* 69.14
2025-01-23 BUY 76 68.930* 69.15
2024-12-10 BUY 1,900 73.390* 69.06
2024-12-09 BUY 228 70.900* 69.02
2024-12-06 SELL -570 71.530* 68.97 Profit of 39,311 on sale
2024-12-05 SELL -38 72.430* 68.89 Profit of 2,618 on sale
2024-12-03 BUY 190 70.200* 68.74
2024-11-27 SELL -228 72.070* 68.45 Profit of 15,607 on sale
2024-11-26 BUY 798 71.550* 68.37
2024-11-25 BUY 100 71.270* 68.29
2024-11-22 SELL -72 70.480* 68.23 Profit of 4,913 on sale
2024-11-21 SELL -190 70.380* 68.17 Profit of 12,952 on sale
2024-11-20 SELL -76 69.540* 68.13 Profit of 5,178 on sale
2024-11-19 BUY 38 70.200* 68.07
2024-11-18 BUY 328 69.890* 68.01
2024-11-11 BUY 114 66.700* 68.18
2024-11-11 BUY 114 66.700* 68.18
2024-11-07 BUY 106 65.840* 68.43
2024-11-07 BUY 106 65.840* 68.43
2024-11-06 BUY 912 65.750* 68.66
2024-11-06 BUY 912 65.750* 68.66
2024-11-05 BUY 190 66.690* 68.83
2024-11-05 BUY 190 66.690* 68.83
2024-11-04 BUY 74 66.470* 69.07
2024-11-04 BUY 74 66.470* 69.07
2024-11-01 BUY 108 67.540* 69.24
2024-11-01 BUY 108 67.540* 69.24
2024-10-30 SELL -228 68.630* 69.65 Profit of 15,879 on sale
2024-10-30 SELL -228 68.630* 69.65 Profit of 15,879 on sale
2024-10-29 SELL -684 69.370* 69.69 Profit of 47,669 on sale
2024-10-29 SELL -684 69.370* 69.69 Profit of 47,669 on sale
2024-10-28 SELL -266 68.520* 69.93 Profit of 18,600 on sale
2024-10-28 SELL -266 68.520* 69.93 Profit of 18,600 on sale
2024-10-21 SELL -38 70.050* 0.00
2024-10-21 SELL -38 70.050* 0.00
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-25	BUY	117	75.270*	72.68
2025-09-18	BUY	468	74.550*	72.67
2025-09-17	BUY	585	75.200*	72.66
2025-09-16	BUY	936	75.090*	72.65
2025-08-15	BUY	76	78.260*	72.58
2025-08-13	BUY	39	77.680*	72.55
2025-08-08	BUY	339	78.350*	72.52
2025-08-06	BUY	716	78.610*	72.45
2025-07-31	BUY	195	79.310*	72.37
2025-07-29	BUY	780	80.470*	72.27
2025-07-11	BUY	312	78.050*	72.23
2025-07-10	BUY	351	78.800*	72.19
2025-07-09	BUY	351	77.190*	72.16
2025-07-07	SELL	-234	76.690*	72.11 Profit of 16,874 on sale
2025-07-02	SELL	-958	77.020*	72.02 Profit of 68,995 on sale
2025-06-27	BUY	122	78.210*	71.94
2025-06-26	BUY	117	77.150*	71.91
2025-06-24	SELL	-546	75.850*	71.85 Profit of 39,230 on sale
2025-06-18	BUY	312	73.980*	71.78
2025-06-17	BUY	117	73.270*	71.77
2025-06-16	SELL	-159	74.820*	71.75 Profit of 11,409 on sale
2025-06-12	SELL	-195	75.890*	71.73 Profit of 13,987 on sale
2025-06-11	BUY	413	75.470*	71.70
2025-06-06	BUY	117	77.520*	71.60
2025-06-05	BUY	546	77.770*	71.55
2025-06-04	BUY	76	77.850*	71.51
2025-06-03	SELL	-38	77.720*	71.47 Profit of 2,716 on sale
2025-05-30	SELL	-4,636	78.220*	71.37 Profit of 330,866 on sale
2025-05-29	BUY	106	77.730*	71.32
2025-05-27	BUY	652	76.220*	71.25
2025-05-23	BUY	540	74.990*	71.19
2025-05-22	BUY	266	74.790*	71.16
2025-05-19	BUY	228	78.040*	71.02
2025-05-16	BUY	114	78.000*	70.97
2025-05-15	SELL	-76	76.880*	70.92 Profit of 5,390 on sale
2025-05-14	BUY	38	76.750*	70.87
2025-05-13	BUY	76	75.500*	70.84
2025-05-12	BUY	246	74.800*	70.80
2025-05-09	SELL	-190	73.680*	70.78 Profit of 13,448 on sale
2025-05-08	BUY	76	74.630*	70.75
2025-05-07	BUY	114	75.040*	70.71
2025-05-02	BUY	4,218	75.650*	70.60
2025-04-30	BUY	1,330	75.490*	70.52
2025-04-29	BUY	333	76.280*	70.47
2025-04-28	BUY	266	75.540*	70.42
2025-04-25	BUY	684	76.040*	70.37
2025-04-24	SELL	-798	75.130*	70.33 Profit of 56,123 on sale
2025-04-23	BUY	722	70.460*	70.33
2025-04-22	BUY	304	70.600*	70.33
2025-04-17	BUY	418	71.530*	70.31
2025-04-15	BUY	380	70.760*	70.30
2025-04-11	BUY	608	69.400*	70.31
2025-04-09	BUY	228	69.900*	70.34
2025-04-08	BUY	1,368	67.070*	70.37
2025-04-07	BUY	450	69.000*	70.39
2025-04-04	SELL	-608	69.360*	70.40 Profit of 42,801 on sale
2025-04-02	BUY	5,168	72.050*	70.38
2025-04-01	BUY	38	71.870*	70.36
2025-03-31	BUY	266	72.480*	70.34
2025-03-28	BUY	152	70.910*	70.33
2025-03-27	BUY	72	71.190*	70.33
2025-03-26	BUY	38	71.090*	70.32
2025-03-25	BUY	418	71.240*	70.31
2025-03-24	BUY	468	71.350*	70.30
2025-03-21	SELL	-152	70.460*	70.29 Profit of 10,685 on sale
2025-03-20	BUY	608	70.950*	70.29
2025-03-19	BUY	108	70.900*	70.28
2025-03-18	BUY	1,328	70.340*	70.28
2025-03-17	BUY	266	70.630*	70.27
2025-03-14	BUY	1,976	69.290*	70.29
2025-03-13	BUY	380	67.950*	70.31
2025-03-12	SELL	-1,900	68.510*	70.34 Profit of 133,639 on sale
2025-03-11	SELL	-1,406	68.390*	70.36 Profit of 98,927 on sale
2025-03-10	BUY	418	68.530*	70.38
2025-03-07	BUY	76	70.330*	70.38
2025-03-05	BUY	570	72.850*	70.35
2025-03-04	BUY	646	71.380*	70.34
2025-03-03	BUY	1,216	71.390*	70.32
2025-02-28	BUY	988	71.620*	70.31
2025-02-27	SELL	-190	71.400*	70.29 Profit of 13,356 on sale
2025-02-25	BUY	1,406	71.450*	70.25
2025-02-21	BUY	152	73.300*	70.17
2025-02-18	SELL	-342	75.670*	69.96 Profit of 23,926 on sale
2025-02-14	SELL	-2,318	76.190*	69.77 Profit of 161,717 on sale
2025-02-13	BUY	38	76.000*	69.67
2025-02-12	BUY	374	75.820*	69.57
2025-02-07	SELL	-53	70.350*	69.51 Profit of 3,684 on sale
2025-02-06	BUY	722	70.990*	69.48
2025-02-05	BUY	190	72.100*	69.44
2025-02-04	BUY	228	71.330*	69.41
2025-02-03	BUY	228	71.380*	69.37
2025-01-31	BUY	418	72.450*	69.32
2025-01-29	SELL	-38	71.130*	69.21 Profit of 2,630 on sale
2025-01-28	SELL	-342	72.560*	69.14 Profit of 23,647 on sale
2025-01-27	SELL	-608	69.200*	69.14 Profit of 42,038 on sale
2025-01-24	BUY	456	68.990*	69.14
2025-01-23	BUY	76	68.930*	69.15
2024-12-10	BUY	1,900	73.390*	69.06
2024-12-09	BUY	228	70.900*	69.02
2024-12-06	SELL	-570	71.530*	68.97 Profit of 39,311 on sale
2024-12-05	SELL	-38	72.430*	68.89 Profit of 2,618 on sale
2024-12-03	BUY	190	70.200*	68.74
2024-11-27	SELL	-228	72.070*	68.45 Profit of 15,607 on sale
2024-11-26	BUY	798	71.550*	68.37
2024-11-25	BUY	100	71.270*	68.29
2024-11-22	SELL	-72	70.480*	68.23 Profit of 4,913 on sale
2024-11-21	SELL	-190	70.380*	68.17 Profit of 12,952 on sale
2024-11-20	SELL	-76	69.540*	68.13 Profit of 5,178 on sale
2024-11-19	BUY	38	70.200*	68.07
2024-11-18	BUY	328	69.890*	68.01
2024-11-11	BUY	114	66.700*	68.18
2024-11-11	BUY	114	66.700*	68.18
2024-11-07	BUY	106	65.840*	68.43
2024-11-07	BUY	106	65.840*	68.43
2024-11-06	BUY	912	65.750*	68.66
2024-11-06	BUY	912	65.750*	68.66
2024-11-05	BUY	190	66.690*	68.83
2024-11-05	BUY	190	66.690*	68.83
2024-11-04	BUY	74	66.470*	69.07
2024-11-04	BUY	74	66.470*	69.07
2024-11-01	BUY	108	67.540*	69.24
2024-11-01	BUY	108	67.540*	69.24
2024-10-30	SELL	-228	68.630*	69.65 Profit of 15,879 on sale
2024-10-30	SELL	-228	68.630*	69.65 Profit of 15,879 on sale
2024-10-29	SELL	-684	69.370*	69.69 Profit of 47,669 on sale
2024-10-29	SELL	-684	69.370*	69.69 Profit of 47,669 on sale
2024-10-28	SELL	-266	68.520*	69.93 Profit of 18,600 on sale
2024-10-28	SELL	-266	68.520*	69.93 Profit of 18,600 on sale
2024-10-21	SELL	-38	70.050*	0.00
2024-10-21	SELL	-38	70.050*	0.00

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of EW

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	406,402	0	1,881,727	21.6%
2025-09-18	684,520	1,177	3,487,981	19.6%
2025-09-17	484,322	210	1,603,065	30.2%
2025-09-16	811,953	856	2,055,937	39.5%
2025-09-15	611,012	104	1,391,882	43.9%
2025-09-12	982,928	1,100	2,234,227	44.0%
2025-09-11	514,234	828	1,919,009	26.8%
2025-09-10	669,705	149	1,567,941	42.7%
2025-09-09	441,493	0	925,375	47.7%
2025-09-08	632,587	672	1,251,939	50.5%
2025-09-05	334,037	300	934,006	35.8%
2025-09-04	380,318	0	871,931	43.6%
2025-09-03	701,943	459	1,170,966	59.9%
2025-09-02	397,396	53	1,208,872	32.9%
2025-08-29	397,628	800	844,318	47.1%
2025-08-28	604,087	4	1,056,653	57.2%
2025-08-27	493,608	822	875,886	56.4%
2025-08-26	480,268	0	868,213	55.3%
2025-08-25	796,556	0	1,181,258	67.4%
2025-08-22	552,739	1	1,011,678	54.6%
2025-08-21	873,044	798	1,597,742	54.6%
2025-08-20	847,847	38,699	1,560,105	54.3%
2025-08-19	613,349	33	1,256,577	48.8%
2025-08-18	668,719	439	1,642,759	40.7%
2025-08-15	369,455	513	826,723	44.7%
2025-08-14	514,202	6,112	864,593	59.5%
2025-08-13	567,857	299	1,347,264	42.1%
2025-08-12	547,773	12,316	1,428,277	38.4%
2025-08-11	487,823	0	1,152,630	42.3%
2025-08-08	661,697	20	1,224,458	54.0%
2025-08-07	669,931	982	1,297,469	51.6%
2025-08-06	880,028	413	1,551,659	56.7%
2025-08-05	661,933	8	1,592,649	41.6%
2025-08-04	572,165	268	1,310,044	43.7%
2025-08-01	678,028	5,600	1,308,863	51.8%
2025-07-31	831,401	249	1,817,975	45.7%
2025-07-30	1,305,016	693	2,481,808	52.6%
2025-07-29	1,129,154	58	2,399,223	47.1%
2025-07-28	684,101	2,111	2,276,892	30.0%
2025-07-25	1,669,752	920	6,616,259	25.2%
2025-07-24	455,593	0	2,607,898	17.5%
2025-07-23	444,645	0	1,978,110	22.5%
2025-07-22	447,883	511	2,702,925	16.6%
2025-07-21	568,293	27	1,249,727	45.5%
2025-07-18	590,448	59	2,118,402	27.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares MSCI USA ESG Screened UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	SDUS(USD) LSE
ETF Ticker	SLUS(EUR) F
ETF Ticker	SDUS.LS(USD) CXE
ETF Ticker	SLUS.DE(EUR) CXE
ETF Ticker	SDUS.L(GBP) LSE